Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by
loss of upper and lower motor neurons, resulting in progressive weakness of all voluntary …

During early postnatal development, sensory regions of the brain undergo periods of
heightened plasticity which sculpt neural networks and lay the foundation for adult sensory …

Introduction Multiple immunity biomarkers have been suggested as tracers of neuroinflammation
in neurodegeneration. This study aimed to verify findings in cerebrospinal fluid (CSF) …

Most individuals with rare diseases initially consult their primary care physician. For a subset
of rare diseases, efficient diagnostic pathways are available. However, ultra-rare diseases …

Amyotrophic lateral sclerosis (ALS) is an invariably fatal neurodegenerative disease with
limited therapeutic options. There is an urgent need for novel biomarkers to be used as …

There is growing evidence that promising biomarkers of inflammation in Alzheimers disease
(AD) and other neurodegenerative diseases correlate strongest to levels of tau or …

Activation of the innate immune system following pattern recognition receptor binding has
emerged as one of the major pathogenic mechanisms in neurodegenerative disease. …

Amyotrophic lateral sclerosis is a devastating neurodegenerative disease characterized by
progressive loss of upper and lower motor neurons. Diagnosis, management and therapeutic …

Arc/Arg3.1, an activity regulated immediate early gene, is essential for learning and memory,
synaptic plasticity, and maturation of neural networks. It has also been implicated in several …

Superficial siderosis of the central nervous system (SS-CNS) is a rare condition characterized
by a hemosiderin accumulation along the subpial surfaces and arises from an intermittent …